Speaker
Dr
Elisabeth Schültke
(Universitätsmedizin Rostock)
Description
Microbeam radiotherapy (MRT) is a synchrotron-based approach to spatial dose fractionation at the micrometer range. Pre-clinical data suggest that MRT can help to control malignant tumours which are considered radioresistant in clinical radiotherapy.
The international MRT research community expects to see first clinical trials at the European Synchrotron Radiation Facility (ESRF) in France and at the Australian Synchrotron in Melbourne within the next six to ten years.
A brief overview will describe what has been achieved already, followed by a discussion of the potential future development of MRT and how microbeam research could contribute to the biomedical scientific portfolio of the PETRA synchrotron on the DESY campus in Hamburg.
Primary author
Dr
Elisabeth Schültke
(Universitätsmedizin Rostock)
Co-author
Dr
Stefan Fiedler
(EMBL Hamburg)
